Most participants in clinical trials lost 1-2% of body weight during this initial month, primarily from the modest GLP-1 activation reducing caloric intake slightly
Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial (Jastreboff et al.)
Because retatrutide is investigational, patients should not rely on online seller claims, informal dosing protocols, or research chemical instructions
Constipation may follow a less predictable pattern, and month 3 is not a guaranteed side-effect finish line
GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists, were first developed to help people with type 2 diabetes manage their blood sugar levels
In comparison, weight loss drugs Wegovy, Ozempic and Mounjaro only work on the and GIP and GLP-1 receptor agonist